FROM Nick Stockton
Theranos Investigations and Silicon Valley Dealmaking The bad news continues to roll in for Theranos, the Silicon Valley-based blood-testing company that was previously valued at $9 billion. Just a few years ago, the company’s wunderkind C.E.O. Elizabeth Holmes was the subject of glowing media profiles. Today, the company she founded is the subject of a criminal probe by the Justice Department, and is also being investigated by the Securities and Exchange Commission over allegations of fraud. Regulators are also considering banning Holmes from owning or running blood-testing labs for two years. How unique is a probe into a company like this? What do the investigations into Theranos say about deal making in Silicon Valley?
Mixed Messages from US diplomats on the new hard line on Syria Since President Trump's surprise retaliation against Syria's use of chemical weapons, Bashar al-Assad has used the same airport to launch conventional attacks on his own people. It's not clear what the US, its allies — or Vladimir Putin's Russia -- plan to do now.
After Syria strike a new Trump doctrine emerges The President who promised an end to entanglements in the Middle East and snuggled up to Vladimir Putin has now outraged Russia with surprise missile attacks on Syria. That's raised questions about who's running the White House? We hear a variety of answers.
"Tough on crime" rhetoric sees a revival at Sessions' DOJ The pendulum swings between treatment-focused approaches to drug abuse and tough law enforcement. Now, after years of Obama-era "reforms," President Trump’s Attorney General, Jeff Sessions wants local police freed from federal restrictions to fight another "war on drugs."
Truth and Lies in Trumpland Donald Trump is using mis-information like no President has before him. It's an unprecedented challenge to the news media, and a potential threat to democracy. We hear how the "leader of all the people" is dividing Americans and confusing the rest of the world.